| Net Cash Provided by (Used in) Operating Activities |
$30,000 |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,480,521 |
shares |
1.5% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$30,000 |
USD |
-115% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$10,571,000 |
USD |
3.2% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$311,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$446,000 |
USD |
63% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$2,543,000 |
USD |
-3.2% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$41,000 |
USD |
116% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$23,000 |
USD |
-4.2% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$532,000 |
USD |
39% |
Q4 2024 |
FY 2024 |